Decibel Therapeutics, Inc

AVI BioPharma is a biopharmaceutical company that develops drugs to treat life-threatening diseases using its patented third generation antisense technology. It has completed clinical trials with its NeuGene antisense drugs in more than 300 subjects, addressing cardiovascular restenosis, infectious diseases, cancer, polycystic kidney disease and drug metabolism. Its most advanced cardiovascular program is for restenosis, where it has completed Phase II trials, evaluating its drug, Resten-NG. AVI BioPharma is also in a Phase II clinical trial with a drug for Hepatitis C infection and its influenza A drug candidate has been confirmed to have efficacy against avian influenza H5N1 in preclinical studies. AVI BioPharma maintains a location in Portland, Ore.

Wyzer Biosciences is a cutting-edge biotechnology company based in Cambridge, MA, specializing in innovative research and development within the life sciences industry. With a focus on advancing technologies and solutions in the field of biosciences, Wyzer Biosciences is dedicated to pushing the boundaries of scientific discovery and driving progress in healthcare and beyond. Generated from their business information

Cogent Biosciences, Inc. is a biotechnology company dedicated to developing precision therapies for genetically driven diseases. With a focus on leveraging validated biology, the company aims to address the underlying causes of illnesses, including cancers, autoimmune conditions, and rare diseases, to enhance patient outcomes. Headquartered in Waltham, Massachusetts, Cogent boasts a world-class discovery organization in Boulder, Colorado, that specializes in pioneering small molecule therapeutics. The company is committed to delivering innovative solutions to patients with unmet medical needs, driven by a passion for transforming lives through science. Generated from the website